Global burden and developments in pre- and post-menopausal estrogen-related cancer from 1990 to 2021, with estimates for 2035.

ABSTRACT:

Introduction

The global prevalence of estrogen-related cancers is often underappreciated, with a significant impact on women's health. Our goal is to explore the patterns and trends in estrogen-related cancers among women, both pre- and post-menopausal, spanning from 1990 to 2021. We conducted secondary analyses to assess the burden of estrogen-related cancers using data from GBD 2021.

Material and methods

We sourced data from the Global Burden of Disease Study (GBD) 2021, focusing on the incidence, mortality, and disability-adjusted life years (DALYs) for two predominant estrogen-related cancers: breast and ovarian cancer. This data encompassed 204 countries and territories, covering a period from 1990 to 2021. We calculated the estimated annual percentage changes (EAPC) ac

SUBMITTER: Qiao X 

PROVIDER: S-EPMC12703480 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature